BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Büll C, Heise T, Adema GJ, Boltje TJ. Sialic Acid Mimetics to Target the Sialic Acid-Siglec Axis. Trends Biochem Sci 2016;41:519-31. [PMID: 27085506 DOI: 10.1016/j.tibs.2016.03.007] [Cited by in Crossref: 82] [Cited by in F6Publishing: 73] [Article Influence: 13.7] [Reference Citation Analysis]
Number Citing Articles
1 Ohira S, Yasuda Y, Tomita I, Kitajima K, Takahashi T, Sato C, Tanaka H. Synthesis of end-functionalized glycopolymers containing α(2,8) disialic acids via π-allyl nickel catalyzed coordinating polymerization and their interaction with Siglec-7. Chem Commun 2017;53:553-6. [DOI: 10.1039/c6cc07115e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
2 van de Wall S, Santegoets KC, van Houtum EJ, Büll C, Adema GJ. Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment. Trends in Immunology 2020;41:274-85. [DOI: 10.1016/j.it.2020.02.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 17.0] [Reference Citation Analysis]
3 Kang F, Chen W, Wang L, Zhang Y. The diverse functions of Siglec-15 in bone remodeling and antitumor responses. Pharmacological Research 2020;155:104728. [DOI: 10.1016/j.phrs.2020.104728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Zhang Y, Wang R, Feng Y, Ma F. The role of sialyltransferases in gynecological malignant tumors. Life Sci 2020;263:118670. [PMID: 33121992 DOI: 10.1016/j.lfs.2020.118670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Haas Q, Simillion C, von Gunten S. A Cartography of Siglecs and Sialyltransferases in Gynecologic Malignancies: Is There a Road Towards a Sweet Future? Front Oncol 2018;8:68. [PMID: 29594046 DOI: 10.3389/fonc.2018.00068] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
6 van Houtum EJH, Büll C, Cornelissen LAM, Adema GJ. Siglec Signaling in the Tumor Microenvironment. Front Immunol 2021;12:790317. [PMID: 34966391 DOI: 10.3389/fimmu.2021.790317] [Reference Citation Analysis]
7 Peng W, Paulson JC. CD22 Ligands on a Natural N-Glycan Scaffold Efficiently Deliver Toxins to B-Lymphoma Cells. J Am Chem Soc 2017;139:12450-8. [PMID: 28829594 DOI: 10.1021/jacs.7b03208] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 7.4] [Reference Citation Analysis]
8 Shimoda A, Tahara Y, Sawada SI, Sasaki Y, Akiyoshi K. Glycan profiling analysis using evanescent-field fluorescence-assisted lectin array: Importance of sugar recognition for cellular uptake of exosomes from mesenchymal stem cells. Biochem Biophys Res Commun 2017;491:701-7. [PMID: 28751214 DOI: 10.1016/j.bbrc.2017.07.126] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 11.0] [Reference Citation Analysis]
9 Zhao Y, Pu M, Zhang J, Wang Y, Yan X, Yu L, He Z. Recent advancements of nanomaterial-based therapeutic strategies toward sepsis: bacterial eradication, anti-inflammation, and immunomodulation. Nanoscale 2021;13:10726-47. [PMID: 34165483 DOI: 10.1039/d1nr02706a] [Reference Citation Analysis]
10 Moons SJ, Adema GJ, Derks MT, Boltje TJ, Büll C. Sialic acid glycoengineering using N-acetylmannosamine and sialic acid analogs. Glycobiology 2019;29:433-45. [PMID: 30913290 DOI: 10.1093/glycob/cwz026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Jin X, Zhang J, Jin X, Liu L, Tian X. Folate Receptor Targeting and Cathepsin B-Sensitive Drug Delivery System for Selective Cancer Cell Death and Imaging. ACS Med Chem Lett 2020;11:1514-20. [PMID: 32832017 DOI: 10.1021/acsmedchemlett.0c00031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
12 Balneger N, Cornelissen LAM, Wassink M, Moons SJ, Boltje TJ, Bar-Ephraim YE, Das KK, Søndergaard JN, Büll C, Adema GJ. Sialic acid blockade in dendritic cells enhances CD8+ T cell responses by facilitating high-avidity interactions. Cell Mol Life Sci 2022;79:98. [PMID: 35089436 DOI: 10.1007/s00018-021-04027-x] [Reference Citation Analysis]
13 Blundell PA, Lu D, Wilkinson M, Dell A, Haslam S, Pleass RJ. Insertion of N-Terminal Hinge Glycosylation Enhances Interactions of the Fc Region of Human IgG1 Monomers with Glycan-Dependent Receptors and Blocks Hemagglutination by the Influenza Virus. J Immunol 2019;202:1595-611. [PMID: 30683699 DOI: 10.4049/jimmunol.1801337] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
14 Wang Z, Geng Z, Shao W, Liu E, Zhang J, Tang J, Wang P, Sun X, Xiao L, Xu W, Zhang Y, Cui H, Zhang L, Yang X, Chang X, Qiu X. Cancer-derived sialylated IgG promotes tumor immune escape by binding to Siglecs on effector T cells. Cell Mol Immunol 2020;17:1148-62. [PMID: 31754235 DOI: 10.1038/s41423-019-0327-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
15 Yamakawa N, Yasuda Y, Yoshimura A, Goshima A, Crocker PR, Vergoten G, Nishiura Y, Takahashi T, Hanashima S, Matsumoto K, Yamaguchi Y, Tanaka H, Kitajima K, Sato C. Discovery of a new sialic acid binding region that regulates Siglec-7. Sci Rep 2020;10:8647. [PMID: 32457377 DOI: 10.1038/s41598-020-64887-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
16 Kim YH, Min KH, Wang Z, Kim J, Jacobson O, Huang P, Zhu G, Liu Y, Yung B, Niu G, Chen X. Development of Sialic Acid-coated Nanoparticles for Targeting Cancer and Efficient Evasion of the Immune System. Theranostics 2017;7:962-73. [PMID: 28382168 DOI: 10.7150/thno.19061] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
17 Yang D, Yang L, Cai J, Hu X, Li H, Zhang X, Zhang X, Chen X, Dong H, Nie H, Li Y. A sweet spot for macrophages: Focusing on polarization. Pharmacol Res 2021;167:105576. [PMID: 33771700 DOI: 10.1016/j.phrs.2021.105576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Xu C, Wang S, Wu Y, Sun X, Yang D, Wang S. Recent advances in understanding the roles of sialyltransferases in tumor angiogenesis and metastasis. Glycoconj J 2021;38:119-27. [PMID: 33411077 DOI: 10.1007/s10719-020-09967-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Rodrigues E, Macauley MS. Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities. Cancers (Basel) 2018;10:E207. [PMID: 29912148 DOI: 10.3390/cancers10060207] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 19.8] [Reference Citation Analysis]
20 Di Carluccio C, Crisman E, Manabe Y, Forgione RE, Lacetera A, Amato J, Pagano B, Randazzo A, Zampella A, Lanzetta R, Fukase K, Molinaro A, Crocker PR, Martín‐santamaría S, Marchetti R, Silipo A. Characterisation of the Dynamic Interactions between Complex N ‐Glycans and Human CD22. ChemBioChem 2020;21:129-40. [DOI: 10.1002/cbic.201900295] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
21 Delaveris CS, Chiu SH, Riley NM, Bertozzi CR. Modulation of immune cell reactivity with cis-binding Siglec agonists. Proc Natl Acad Sci U S A 2021;118:e2012408118. [PMID: 33431669 DOI: 10.1073/pnas.2012408118] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
22 Jarahian M, Marofi F, Maashi MS, Ghaebi M, Khezri A, Berger MR. Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape. Cancers (Basel) 2021;13:5203. [PMID: 34680351 DOI: 10.3390/cancers13205203] [Reference Citation Analysis]
23 Jaeger M, Pinelli M, Borghi M, Constantini C, Dindo M, van Emst L, Puccetti M, Pariano M, Ricaño-Ponce I, Büll C, Gresnigt MS, Wang X, Gutierrez Achury J, Jacobs CWM, Xu N, Oosting M, Arts P, Joosten LAB, van de Veerdonk FL, Veltman JA, Ten Oever J, Kullberg BJ, Feng M, Adema GJ, Wijmenga C, Kumar V, Sobel J, Gilissen C, Romani L, Netea MG. A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis. Sci Transl Med 2019;11:eaar3558. [PMID: 31189718 DOI: 10.1126/scitranslmed.aar3558] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
24 Prescher H, Frank M, Gütgemann S, Kuhfeldt E, Schweizer A, Nitschke L, Watzl C, Brossmer R. Design, Synthesis, and Biological Evaluation of Small, High-Affinity Siglec-7 Ligands: Toward Novel Inhibitors of Cancer Immune Evasion. J Med Chem 2017;60:941-56. [DOI: 10.1021/acs.jmedchem.6b01111] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
25 Heise T, Pijnenborg JFA, Büll C, van Hilten N, Kers-Rebel ED, Balneger N, Elferink H, Adema GJ, Boltje TJ. Potent Metabolic Sialylation Inhibitors Based on C-5-Modified Fluorinated Sialic Acids. J Med Chem 2019;62:1014-21. [PMID: 30543426 DOI: 10.1021/acs.jmedchem.8b01757] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
26 Chiodelli P, Urbinati C, Paiardi G, Monti E, Rusnati M. Sialic acid as a target for the development of novel antiangiogenic strategies. Future Med Chem 2018;10:2835-54. [PMID: 30539670 DOI: 10.4155/fmc-2018-0298] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
27 Saheb Sharif-Askari N, Saheb Sharif-Askari F, Mdkhana B, Al Heialy S, Alsafar HS, Hamoudi R, Hamid Q, Halwani R. Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection. Mol Ther Methods Clin Dev 2021;20:109-21. [PMID: 33200082 DOI: 10.1016/j.omtm.2020.11.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
28 Abdu-Allah HHM, Wu SC, Lin CH, Tseng YY. Design, synthesis and molecular docking study of α-triazolylsialosides as non-hydrolyzable and potent CD22 ligands. Eur J Med Chem 2020;208:112707. [PMID: 32942185 DOI: 10.1016/j.ejmech.2020.112707] [Reference Citation Analysis]
29 Wang X, Qian S, Wang D, Wang C, Qin H, Peng L, Lu W, Zhang Y, Qing G. Self-assembly gel-based dynamic response system for specific recognition of N-acetylneuraminic acid. J Mater Chem B 2021;9:4690-9. [PMID: 34076032 DOI: 10.1039/d1tb00627d] [Reference Citation Analysis]
30 Liu M, Tang X, Ding J, Liu M, Zhao B, Deng Y, Song Y. A Sialylated-Bortezomib Prodrug Strategy Based on a Highly Expressed Selectin Target for the Treatment of Leukemia or Solid Tumors. Pharm Res 2019;36:176. [PMID: 31686241 DOI: 10.1007/s11095-019-2714-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Ghosh S. Nanotechnology and sialic acid biology. Sialic Acids and Sialoglycoconjugates in the Biology of Life, Health and Disease. Elsevier; 2020. pp. 297-325. [DOI: 10.1016/b978-0-12-816126-5.00011-1] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Lin C, Yeh Y, Yang KD. Functions and therapeutic targets of Siglec-mediated infections, inflammations and cancers. Journal of the Formosan Medical Association 2021;120:5-24. [DOI: 10.1016/j.jfma.2019.10.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
33 Saeui CT, Nairn AV, Galizzi M, Douville C, Gowda P, Park M, Dharmarha V, Shah SR, Clarke A, Austin M, Moremen KW, Yarema KJ. Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes. PLoS One 2018;13:e0195812. [PMID: 29847599 DOI: 10.1371/journal.pone.0195812] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
34 Büll C, Nason R, Sun L, Van Coillie J, Madriz Sørensen D, Moons SJ, Yang Z, Arbitman S, Fernandes SM, Furukawa S, McBride R, Nycholat CM, Adema GJ, Paulson JC, Schnaar RL, Boltje TJ, Clausen H, Narimatsu Y. Probing the binding specificities of human Siglecs by cell-based glycan arrays. Proc Natl Acad Sci U S A 2021;118:e2026102118. [PMID: 33893239 DOI: 10.1073/pnas.2026102118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
35 Hong S, Yu C, Wang P, Shi Y, Cao W, Cheng B, Chapla DG, Ma Y, Li J, Rodrigues E, Narimatsu Y, Yates JR 3rd, Chen X, Clausen H, Moremen KW, Macauley MS, Paulson JC, Wu P. Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B-Cell Lymphoma Therapy. Angew Chem Int Ed Engl 2021;60:3603-10. [PMID: 33314603 DOI: 10.1002/anie.202005934] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
36 Visser EA, Moons SJ, Timmermans SBPE, de Jong H, Boltje TJ, Büll C. Sialic acid O-acetylation: From biosynthesis to roles in health and disease. J Biol Chem 2021;297:100906. [PMID: 34157283 DOI: 10.1016/j.jbc.2021.100906] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Meril S, Harush O, Reboh Y, Matikhina T, Barliya T, Cohen CJ. Targeting glycosylated antigens on cancer cells using siglec‐7/9‐based CAR T‐cells. Molecular Carcinogenesis 2020;59:713-23. [DOI: 10.1002/mc.23213] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
38 Ahmad S, Al-Hatamleh MAI, Mohamud R. Targeting immunosuppressor cells with nanoparticles in autoimmunity: How far have we come to? Cell Immunol 2021;368:104412. [PMID: 34340162 DOI: 10.1016/j.cellimm.2021.104412] [Reference Citation Analysis]
39 Movsisyan LD, Macauley MS. Structural advances of Siglecs: insight into synthetic glycan ligands for immunomodulation. Org Biomol Chem 2020;18:5784-97. [PMID: 32756649 DOI: 10.1039/d0ob01116a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
40 Dubois L, Pietrancosta N, Cabaye A, Fanget I, Debacker C, Gilormini PA, Dansette PM, Dairou J, Biot C, Froissart R, Goupil-Lamy A, Bertrand HO, Acher FC, McCort-Tranchepain I, Gasnier B, Anne C. Amino Acids Bearing Aromatic or Heteroaromatic Substituents as a New Class of Ligands for the Lysosomal Sialic Acid Transporter Sialin. J Med Chem 2020;63:8231-49. [PMID: 32608236 DOI: 10.1021/acs.jmedchem.9b02119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
41 Han Z, Thuy-Boun PS, Pfeiffer W, Vartabedian VF, Torkamani A, Teijaro JR, Wolan DW. Identification of an N-acetylneuraminic acid-presenting bacteria isolated from a human microbiome. Sci Rep 2021;11:4763. [PMID: 33637779 DOI: 10.1038/s41598-021-83875-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Jiang KY, Qi LL, Kang FB, Wang L. The intriguing roles of Siglec family members in the tumor microenvironment. Biomark Res 2022;10:22. [PMID: 35418152 DOI: 10.1186/s40364-022-00369-1] [Reference Citation Analysis]
43 Yin SS, Gao FH. Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10. Front Immunol 2020;11:1324. [PMID: 32765491 DOI: 10.3389/fimmu.2020.01324] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
44 Lübbers J, Rodríguez E, van Kooyk Y. Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions. Front Immunol 2018;9:2807. [PMID: 30581432 DOI: 10.3389/fimmu.2018.02807] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 20.0] [Reference Citation Analysis]
45 Bigdelou P, Chan KK, Tang J, Yu KN, Whited J, Wang D, Lee MY, Sun XL. High-throughput multiplex assays with mouse macrophages on pillar plate platforms. Exp Cell Res 2020;396:112243. [PMID: 32835658 DOI: 10.1016/j.yexcr.2020.112243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Kdimati S, Mullins CS, Linnebacher M. Cancer-Cell-Derived IgG and Its Potential Role in Tumor Development. Int J Mol Sci 2021;22:11597. [PMID: 34769026 DOI: 10.3390/ijms222111597] [Reference Citation Analysis]
47 Miles LA, Hermans SJ, Crespi GAN, Gooi JH, Doughty L, Nero TL, Markulić J, Ebneth A, Wroblowski B, Oehlrich D, Trabanco AA, Rives ML, Royaux I, Hancock NC, Parker MW. Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes Aβ Phagocytosis. iScience 2019;19:110-8. [PMID: 31369984 DOI: 10.1016/j.isci.2019.07.023] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
48 [DOI: 10.1101/2020.09.15.288712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Büll C, Heise T, van Hilten N, Pijnenborg JF, Bloemendal VR, Gerrits L, Kers-Rebel ED, Ritschel T, den Brok MH, Adema GJ, Boltje TJ. Steering Siglec-Sialic Acid Interactions on Living Cells using Bioorthogonal Chemistry. Angew Chem Int Ed Engl 2017;56:3309-13. [PMID: 28194834 DOI: 10.1002/anie.201612193] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
50 Büll C, Collado-Camps E, Kers-Rebel ED, Heise T, Søndergaard JN, den Brok MH, Schulte BM, Boltje TJ, Adema GJ. Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation. Immunol Cell Biol 2017;95:408-15. [PMID: 27874015 DOI: 10.1038/icb.2016.105] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
51 Kightlinger W, Warfel KF, DeLisa MP, Jewett MC. Synthetic Glycobiology: Parts, Systems, and Applications. ACS Synth Biol 2020;9:1534-62. [PMID: 32526139 DOI: 10.1021/acssynbio.0c00210] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
52 Wang Y, Zhang P, Wei Y, Shen K, Xiao L, Miron RJ, Zhang Y. Cell-Membrane-Display Nanotechnology. Adv Healthc Mater 2021;10:e2001014. [PMID: 33000917 DOI: 10.1002/adhm.202001014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Nycholat CM, Duan S, Knuplez E, Worth C, Elich M, Yao A, O'Sullivan J, McBride R, Wei Y, Fernandes SM, Zhu Z, Schnaar RL, Bochner BS, Paulson JC. A Sulfonamide Sialoside Analogue for Targeting Siglec-8 and -F on Immune Cells. J Am Chem Soc 2019;141:14032-7. [PMID: 31460762 DOI: 10.1021/jacs.9b05769] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
54 Wang J, Zhao L, Yan B. Indicator Displacement Assay Inside Dye-Functionalized Covalent Organic Frameworks for Ultrasensitive Monitoring of Sialic Acid, an Ovarian Cancer Biomarker. ACS Appl Mater Interfaces 2020;12:12990-7. [DOI: 10.1021/acsami.0c00101] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
55 Bloemendal VRLJ, Moons SJ, Heming JJA, Chayoua M, Niesink O, van Hest JCM, Boltje TJ, Rutjes FPJT. Chemoenzymatic Synthesis of Sialic Acid Derivatives Using Immobilized N-Acetylneuraminate Lyase in a Continuous Flow Reactor. Adv Synth Catal 2019;361:2443-7. [PMID: 31598119 DOI: 10.1002/adsc.201900146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Santegoets KCM, Gielen PR, Büll C, Schulte BM, Kers-Rebel ED, Küsters B, Bossman SAJFH, Ter Laan M, Wesseling P, Adema GJ. Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma. Cancer Immunol Immunother 2019;68:937-49. [PMID: 30953118 DOI: 10.1007/s00262-019-02332-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
57 Lenza MP, Atxabal U, Oyenarte I, Jiménez-Barbero J, Ereño-Orbea J. Current Status on Therapeutic Molecules Targeting Siglec Receptors. Cells 2020;9:E2691. [PMID: 33333862 DOI: 10.3390/cells9122691] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
58 Su L, Feng Y, Wei K, Xu X, Liu R, Chen G. Carbohydrate-Based Macromolecular Biomaterials. Chem Rev 2021. [PMID: 34338501 DOI: 10.1021/acs.chemrev.0c01338] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Hevey R. Bioisosteres of Carbohydrate Functional Groups in Glycomimetic Design. Biomimetics (Basel) 2019;4:E53. [PMID: 31357673 DOI: 10.3390/biomimetics4030053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
60 Ono K, Sanada Y, Kimura Y, Aoyama S, Ueda N, Katayama T, Nagahama K. A thin hydrogel barrier linked onto cell surface sialic acids through covalent bonds induces cancer cell death in vivo. Biomater Sci 2020;8:577-85. [PMID: 31872195 DOI: 10.1039/c9bm01758e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Hetzel M, Ackermann M, Lachmann N. Beyond "Big Eaters": The Versatile Role of Alveolar Macrophages in Health and Disease. Int J Mol Sci 2021;22:3308. [PMID: 33804918 DOI: 10.3390/ijms22073308] [Reference Citation Analysis]
62 Fang RH, Jiang Y, Fang JC, Zhang L. Cell membrane-derived nanomaterials for biomedical applications. Biomaterials 2017;128:69-83. [PMID: 28292726 DOI: 10.1016/j.biomaterials.2017.02.041] [Cited by in Crossref: 187] [Cited by in F6Publishing: 176] [Article Influence: 37.4] [Reference Citation Analysis]
63 Gonzalez-Gil A, Schnaar RL. Siglec Ligands. Cells 2021;10:1260. [PMID: 34065256 DOI: 10.3390/cells10051260] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Liu G, Zhang Y, Zhou L, Jia L, Jiang G, Xing G, Wang S. A water-soluble AIE-active polyvalent glycocluster: design, synthesis and studies on carbohydrate–lectin interactions for visualization of Siglec distributions in living cell membranes. Chem Commun 2019;55:9869-72. [DOI: 10.1039/c9cc05008f] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
65 Yu H, Gonzalez-Gil A, Wei Y, Fernandes SM, Porell RN, Vajn K, Paulson JC, Nycholat CM, Schnaar RL. Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties. Glycobiology 2017;27:657-68. [PMID: 28369504 DOI: 10.1093/glycob/cwx026] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
66 Chu S, Zhu X, You N, Zhang W, Zheng F, Cai B, Zhou T, Wang Y, Sun Q, Yang Z, Zhang X, Wang C, Nie S, Zhu J, Wang M. The Fab Fragment of a Human Anti-Siglec-9 Monoclonal Antibody Suppresses LPS-Induced Inflammatory Responses in Human Macrophages. Front Immunol 2016;7:649. [PMID: 28082984 DOI: 10.3389/fimmu.2016.00649] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
67 Leonhard V, Alasino RV, Pasqualini ME, Cremonezzi DC, García NH, Beltramo DM. Monosialoganglioside GM1 reduces toxicity of Ptx and increase anti-metastasic effect in a murine mammary cancer model. Sci Rep 2020;10:10191. [PMID: 32576898 DOI: 10.1038/s41598-020-67256-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Varki A. Are humans prone to autoimmunity? Implications from evolutionary changes in hominin sialic acid biology. J Autoimmun 2017;83:134-42. [PMID: 28755952 DOI: 10.1016/j.jaut.2017.07.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
69 Valverde P, Ardá A, Reichardt NC, Jiménez-Barbero J, Gimeno A. Glycans in drug discovery. Medchemcomm 2019;10:1678-91. [PMID: 31814952 DOI: 10.1039/c9md00292h] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 8.7] [Reference Citation Analysis]
70 Yu Y, Blokhuis BRJ, Diks MAP, Keshavarzian A, Garssen J, Redegeld FA. Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells. Front Immunol 2018;9:2138. [PMID: 30294327 DOI: 10.3389/fimmu.2018.02138] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
71 Matsubara N, Imamura A, Yonemizu T, Akatsu C, Yang H, Ueki A, Watanabe N, Abdu-Allah H, Numoto N, Takematsu H, Kitazume S, Tedder TF, Marth JD, Ito N, Ando H, Ishida H, Kiso M, Tsubata T. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice. Front Immunol 2018;9:820. [PMID: 29725338 DOI: 10.3389/fimmu.2018.00820] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
72 Forgione RE, Nieto FF, Di Carluccio C, Milanesi F, Fruscella M, Papi F, Nativi C, Molinaro A, Palladino P, Scarano S, Minunni M, Montefiori M, Civera M, Sattin S, Francesconi O, Marchetti R, Silipo A. Conformationally Constrained Sialyl Analogues as New Potential Binders of h-CD22. Chembiochem 2022;:e202200076. [PMID: 35313057 DOI: 10.1002/cbic.202200076] [Reference Citation Analysis]
73 Chang LY, Low PY, Sridharan D, Gerlovin K, Angata T. Preparation of Recombinant Siglecs and Identification of Their Ligands. Methods Mol Biol 2020;2132:85-98. [PMID: 32306317 DOI: 10.1007/978-1-0716-0430-4_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
74 Gianchecchi E, Arena A, Fierabracci A. Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments. Int J Mol Sci 2021;22:5774. [PMID: 34071314 DOI: 10.3390/ijms22115774] [Reference Citation Analysis]
75 Nieto-Garai JA, Contreras FX, Arboleya A, Lorizate M. Role of Protein-Lipid Interactions in Viral Entry. Adv Biol (Weinh) 2022;:e2101264. [PMID: 35119227 DOI: 10.1002/adbi.202101264] [Reference Citation Analysis]
76 Hou R, Huo X, Zhang S, Xu C, Huang Y, Xu X. Elevated levels of lead exposure and impact on the anti-inflammatory ability of oral sialic acids among preschool children in e-waste areas. Sci Total Environ 2020;699:134380. [PMID: 31678878 DOI: 10.1016/j.scitotenv.2019.134380] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
77 Läubli H, Kawanishi K, George Vazhappilly C, Matar R, Merheb M, Sarwar Siddiqui S. Tools to study and target the Siglec-sialic acid axis in cancer. FEBS J 2020. [PMID: 33251699 DOI: 10.1111/febs.15647] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
78 Yoshimura A, Hatanaka R, Tanaka H, Kitajima K, Sato C. The conserved arginine residue in all siglecs is essential for Siglec-7 binding to sialic acid. Biochem Biophys Res Commun 2021;534:1069-75. [PMID: 33248687 DOI: 10.1016/j.bbrc.2020.10.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Yamaguchi S, Yoshimura A, Yasuda Y, Mori A, Tanaka H, Takahashi T, Kitajima K, Sato C. Chemical Synthesis and Evaluation of a Disialic Acid-Containing Dextran Polymer as an Inhibitor for the Interaction between Siglec 7 and Its Ligand. ChemBioChem 2017;18:1194-203. [DOI: 10.1002/cbic.201600694] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]